We evaluated the clinical associations and prognostic value of CSF p- tau, a priori-defined regional tau PET indices (meta-temporal ROI and average Braak score), and a machine learning-derived MRI index (SPARE-AD) [8, 9]. This evidence concerns the gene MAPT and Alzheimer disease.